Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

Neuroblastom: Künftig bessere Therapie-Chancen ...Alle News – Medizin & Wissenschaft (Wien, 03-12-2019) Das Neuroblastom ist ein seltener bösartiger Tumor, an dem insbesondere Kinder unter sechs Jahren erkranken können. Ein Forschungsteam um den Molekularpathologen Lukas Kenner von der Klinischen Abteilung für Pathologie... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-dezember-2020/neuroblastom-kuenftig-bessere-therapie-chancen/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=c75bfbba2ee89372a0cb0d7c37db1ff5
Neuroblastom: Künftig bessere Therapie-Chancen ...Alle News – Medizin & Wissenschaft (Wien, 03-12-2019) Das Neuroblastom ist ein seltener bösartiger Tumor, an dem insbesondere Kinder unter sechs Jahren erkranken können. Ein Forschungsteam um den Molekularpathologen Lukas Kenner von der Klinischen Abteilung für Pathologie... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-dezember-2020/neuroblastom-kuenftig-bessere-therapie-chancen/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=6a9996b8fd5e8e08df425b14a7391736
News ...). Dies haben Heidelberger und Wiener Wissenschafter um den Pathologen Lukas Kenner (MedUni Wien, Ludwig Boltzmann Institut für Krebsforschung und VetMedUniWien) herausgefunden und vor kurzem im renommierten "Journal of Pathology" publiziert."ALCL ist ein seltenes, aggressives Non-Hodgkin-Lymphom, das oft bei jungen Patienten vorkommt", sagte Kenner vom Klinischen Institut für Pathologie im Wiener AKH. Lymphome sind eine Art von Blutkrebs, wobei es aber zur Entstehung von Tumoren kommt. Etwa bei der Hälfte der ALCL-Patienten liegt eine Genveränderung vor, die zum Entstehen eines Fusionsproteins (NPM... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=2885&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=35b34b57009a1c59708fafb9c319691c
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/index.php?id=688&res=kilian__kluge
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/1/forschung/researcher-profiles/researcher-profiles/index.php?id=688&res=kilian__kluge
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?res=kilian__kluge&cHash=0016747d495c91eb72d200e08efcc3f5
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?res=kilian__kluge&cHash=c2bde58355e86017ab91c890e829af2f
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/index.php?id=688&res=kilian__kluge
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/index.php?id=688&res=kilian__kluge
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?name=Kilian%20_Kluge&res_id=979&cHash=c39e970a8d18955a9e03d21559118f83